Related Experiment Video
Updated: Jul 5, 2026

05:13
Establishment of an Embryo Implantation Model In Vitro
Published on: June 21, 2024
A multiple marker model to predict pregnancy viability when progesterone is indeterminate
Beth J Plante1, Jeffrey D Blume, Geralyn Lambert-Messerlian
1Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown Medical School, USA. bethplante@gmail.com
The Journal of Reproductive Medicine
|May 14, 2008
Summary
A new multiple marker model accurately predicts pregnancy viability in symptomatic women during the first trimester. This model combines progesterone levels with other factors for improved diagnostic accuracy.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Endocrinology
- Clinical Diagnostics
Background:
- Early pregnancy viability assessment is crucial for symptomatic women.
- Differentiating viable from nonviable pregnancies often requires multiple visits and tests.
- Accurate prediction at a single visit can improve patient management and reduce anxiety.
Purpose of the Study:
- To develop and validate a predictive model for pregnancy viability.
- To assess the diagnostic accuracy of single and multiple biomarkers.
- To identify key predictors for differentiating viable from nonviable first-trimester pregnancies.
Main Methods:
- Prospective cohort study of 256 symptomatic first-trimester women.
- Collection of clinical data, serum biomarkers (including progesterone and human chorionic gonadotropin), and ultrasound findings.
- Analysis using receiver operator characteristic curves to evaluate predictor accuracy.
Main Results:
- Progesterone demonstrated high accuracy in predicting viability, especially at extreme values (AUC=0.99).
- A multiple marker model incorporating progesterone, hCG, ultrasound, and symptoms achieved 90% accuracy (AUC=0.90) in the 'grey zone'.
- The model effectively differentiated viable from nonviable pregnancies in symptomatic women.
Conclusions:
- A multiple marker model provides accurate prediction of pregnancy viability in symptomatic women.
- This model can aid in timely diagnosis and management decisions during the first trimester.
- Integrating multiple biomarkers enhances diagnostic performance beyond single marker assessment.

